Scotiabank Reiterates Sector Outperform Rating on Sage Therapeutics (SAGE)

October 9, 2024 11:46 AM EDT Send to a Friend
Scotiabank analyst George Farmer reiterated a Sector Outperform rating and $17.00 price target on Sage Therapeutics (NASDAQ: SAGE).The analyst commented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login